Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Injections × Thoracic × Clear all

Phase

Phase 2 16 Phase 1/2 12 Phase 3 11 Phase 1 11 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Other hematologic neoplasm 2 Myeloid 2 Thoracic 1 Other solid neoplasm 1 NET 1 Genitourinary 1 Endocrine 1

Conditions

Thoracic Neoplasms 1

Interventions

Pemetrexed 19 Carboplatin 18 Cisplatin 17 pembrolizumab 14 Docetaxel 12 Paclitaxel 9 Gemcitabine 6 Gefitinib 5 Drug Therapy 5 Bevacizumab 5 Erlotinib Hydrochloride 4 130-nm albumin-bound paclitaxel 4 anlotinib 3 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 cemiplimab 2 aumolertinib 2 atezolizumab 2 apatinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Leucovorin 2 Dexamethasone 2 trametinib 1 toripalimab 1 tislelizumab 1 spartalizumab 1 sintilimab 1 rofecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04209868 2024-03-29

ParaSOL

Guy's and St Thomas' NHS Foundation Trust

Phase 2/3 Recruiting

Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡